Previous 10 | Next 10 |
2023-07-21 09:59:48 ET Summary IDEXX Laboratories, a leader in pet diagnostic and software products, is targeting 10%+ organic sales growth and 15-20% EPS growth, making it a high-quality company. The company is focusing on diagnostics penetration growth and software solutions, wi...
2023-07-19 18:40:53 ET Summary Zoetis, a global leader in animal health, has seen significant growth since its spin-off from Pfizer, particularly in the companion animal sector due to increased pet ownership. Key risks for Zoetis include potential animal plagues, distributors dest...
BRADENTON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the appointment of Irene Chang Britt to its Bo...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company's Board of Directors, effective July 11, 2023. "We are pleased to welcome Irene to the IDEXX Bo...
2023-07-11 12:10:00 ET Summary The Fundsmith Equity Fund reported an 8.5% increase in the first half of 2023, with Meta, Microsoft, L’Oréal, LVMH, and Amadeus being the biggest positive contributors. The Fund's biggest detractors were Waters, Mettler-Toledo, Estée...
2023-06-29 18:01:38 ET Summary IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical customers, strong pricing power, and high free cash flow co...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. ...
2023-06-18 06:55:43 ET Summary IDEXX Laboratories is a global company that provides products and services for primarily companion animals. Revenue has grown at a rate of 10%, driven by improving market conditions and an expansion of IDEXX's operations. Commercially, the market...
2023-06-15 21:58:41 ET Summary Ron Baron's 13F portfolio value increased from $29.78B to $33.31B in Q1 2023, with Tesla, Gartner, Arch Capital Group, CoStar Group and MSCI as the largest five stakes. Baron Capital has a common theme of long-term research-driven growth investment s...
IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio PR Newswire The IDEXX Cystatin B Test can help veterinarians detect kidney injury before changes in kidney function, promoting better patient...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories Inc. Website:
2024-07-19 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 23:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day. ...